Pharmaceutical Policy

Publications authored by CHSPR faculty and staff from 2009 to the present are listed here. Older peer-reviewed publications are usually available from individual journals and can be searched for using PubMed. Older reports published by CHSPR (from 1973) are available from the UBC Library cIRcle database. If you cannot find a specific publication, please contact us.


Gomes T, Martins D, Cheng L, Kratzer J, Juurlink DN, Shah BR, Mamdani MM, Paterson JM, Law MR. The impact of policies to reduce blood glucose test strip utilization and costs in Canada. Can J Public Health. 2015 Apr 30;106(4):e210-6. Read more

Morgan SG, Law M, Daw JR, Abraham L, Martin D. Estimated cost of universal public coverage of prescription drugs in Canada. CMAJ. 2015 Apr 21;187(7):491-7. Read more

Hohl CM, McGrail K, Sobolev B. The effect of pharmacist-led medication review in high-risk patients in the emergency department: an evaluation protocol. CMAJ Open. 2015 Jan 13;3(1):E103-10. Read more

Morgan SG, Daw JR, Thomson PA. Pharmaceuticals. In: Marchildon GP, Di Matteo L, editors. Bending the cost curve in health care: Canada's provinces in international perspective. Toronto: University of Toronto Press, Higher Education Division; 2014. Read more

Law MR, Kratzer J, Cheng L, Donovan S. Utilization patterns and reimbursement options for diabetes test strips in British Columbia. Vancouver (BC): UBC Centre for Health Services and Policy Research; June 2014. Read more

Smolina K, Morgan S. The drivers of overspending on prescription drugs in Quebec. Healthc Policy. 2014 Nov;10(2):19-26. Read more

Zillich AJ, Snyder ME, Frail CK, Lewis JL, Deshotels D, Grove S, Dunham P, Jaynes H, and Sutherland J.M. A randomized controlled pragmatic trial of telephonic medication therapy management to reduce hospitalization in home health patients. Health Serv Res. 2014 Oct;49(5):1537-54. Read more

Daw JR Morgan SG, Collins PA, Abelson J. Framing incremental expansions to public health insurance systems: the case of Canadian pharmacare. J Health Polit Policy Law. 2014 Apr;39(2):295-330. Read more

Moore SE, McGrail KM, Peterson S, Raval MJ, Karimuddin AA, Phang PT, Bressler B, Brown CJ. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada. Dis Colon Rectum. 2014 Jan;57(1):83-90. Read more

Puyat JH, Daw JR, Cunningham CM, Law MR, Wong ST, Greyson DL, Morgan SG. Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2013 Dec;48(12):1861-72. Read more

Morgan S, Smolina K, Mooney D, Raymond C, Bowen M, Gorczynski C, Rutherford K. Canadian Rx atlas. 3rd edition. Vancouver (BC): UBC Centre for Health Services and Policy Research; Dec 2013. Read more

Balaban DY, Dhalla IA, Law MR, Bell CM. Private expenditures on brand name prescription drugs after generic entry.Appl Health Econ Health Policy. 2013 Oct;11(5):523-9. Read more

Mintzes B, Lexchin J, Sutherland JM, Beaulieu MD, Wilkes MS, Durrieu G, Reynolds E. Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States. J Gen Intern Med. 2013 Oct;28(10):1368-75. Read more

Morgan SG, Thomson PA, Daw JR, Friesen MK. Canadian policy makers' views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers. Health Policy. 2013 Oct;112(3):248-54. Read more

Law MR, Kratzer J.  The road to competitive generic drug prices in Canada. CMAJ. 2013 Sep 17;185(13):1141-4. Read more

Kratzer J, McGrail K, Strumpf E, Law MR. Cost-control mechanisms in Canadian private drug plans. Healthc Policy. 2013 Aug;9(1):35-43. Read more

Morgan S, Daw J, Law M. Rethinking Pharmacare in Canada. Toronto (ON): C.D. Howe Institute; Jun 2013. Commentary no.384. Read more

Morgan SG, Friesen MK, Thomson PA, Daw JR. Use of product listing agreements by Canadian provincial drug benefit plans. Healthc Policy. 2013 May;8(4):45-55. Read more

Allin S, Law MR, Laporte A. How does complementary private prescription drug insurance coverage affect seniors' use of publicly funded medications? Health Policy. 2013 May;110(2-3):147-55. Read more

Daw JR, Morgan SG, Thomson PA, Law MR. Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada. Health Policy. 2013 Apr;110(1):67-75. Read more